These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2157676)

  • 1. Morphologic analysis of human lymphokine-activated killer (LAK) cells.
    Groscurth P; Diener S; Stahel R; Jost L; Kägi D; Hengartner H
    Int J Cancer; 1990 Apr; 45(4):694-704. PubMed ID: 2157676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy.
    Streck RJ; Helinski EH; Ovak GM; Pauly JL
    J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural characteristics of lymphokine-activated killer cells of the rat in comparison with natural killer cells.
    Kaneda K; Nagamuta M; Kataoka M; Yamamoto H; Kishiye T; Wake K
    Arch Histol Cytol; 1991 May; 54(2):119-32. PubMed ID: 1873071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effector cells of the immune system.
    Groscurth P
    Anat Embryol (Berl); 1989; 180(2):109-19. PubMed ID: 2679226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.
    Melder RJ; Walker ER; Herberman RB; Whiteside TL
    J Leukoc Biol; 1990 Aug; 48(2):163-73. PubMed ID: 1973444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells.
    Liu CC; Walsh CM; Eto N; Clark WR; Young JD
    J Immunol; 1995 Jul; 155(2):602-8. PubMed ID: 7608538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrastructural study of the lethal effect of lymphokine activated killer (LAK) cell on liver cancer cells].
    Chen DH
    Zhonghua Bing Li Xue Za Zhi; 1991 Sep; 20(3):190-2. PubMed ID: 1782688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.
    Subauste CS; Dawson L; Remington JS
    J Exp Med; 1992 Dec; 176(6):1511-9. PubMed ID: 1460415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between ultrastructural and histochemical parameters in lymphokine-activated killer (LAK) cells reacting with target cells in vitro.
    Nano R; Barni S; Capelli E; Cremaschi P; Catanese C; Tomaselli S; Nascimbene C; Prosperi E
    Acta Oncol; 1994; 33(2):165-9. PubMed ID: 7515629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electron microscopic observation on the killing of human lung carcinoma cells by lymphokine-activated killer cells (LAK cells) in vitro].
    Shi J
    Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):319-21, 22. PubMed ID: 2169980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture.
    Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R
    Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target cell membrane modification and susceptibility to lymphokine-activated killer cell-mediated lysis. II. Sodium periodate has a differential effect on the lysis of human and murine tumor cells.
    Midis GP; Gupta VK; Fabian DF; Lefor AT
    J Surg Res; 1994 Feb; 56(2):146-54. PubMed ID: 8121171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoelectron microscopic studies on the process of tumor cytolysis mediated by lymphokine activated NK cells].
    Gong YH; Guo X; Zhang XQ
    Zhonghua Bing Li Xue Za Zhi; 1994 Feb; 23(1):17-9. PubMed ID: 8044855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q; Nakadai A; Takeda K; Kawada T
    Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of mucoid material by lymphokine-activated killer cells: study by light and electron microscopy.
    Ginsburg H; Coleman R; Davidson S; Yahav H; Khoury C
    J Leukoc Biol; 1990 May; 47(5):393-408. PubMed ID: 2186162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.
    Lowrey DM; Hameed A; Lichtenheld M; Podack ER
    Cancer Res; 1988 Aug; 48(16):4681-8. PubMed ID: 3260817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells.
    Shresta S; MacIvor DM; Heusel JW; Russell JH; Ley TJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5679-83. PubMed ID: 7777569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated killer-cell-mediated killing of WiDr colon carcinoma cells is inhibited by K562 erythroleukemia cells.
    Dullens HF; Wind JC; Maas RA; Bernsen MR; Vulto IM; Rademakers LH; Den Otter W
    Int Immunol; 1991 Oct; 3(10):959-64. PubMed ID: 1756146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.